Form 4/A for PLSE PULSE BIOSCIENCES, INC.
Accepted 2023-07-06 00:00:00 ET · period of report 2023-06-12 · accession 0001437749-23-019539 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2023-07-06 | 2023-06-12 | PLSE | UECKER DARRIN | CTO, Dir | X - OptEx | $2.05 | +7,365 | 148.9K | +5% | +$15.1K |
| DA | 2023-07-06 | 2023-06-12 | PLSE | UECKER DARRIN | CTO, Dir | X - OptEx | $0.00 | -7,365 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-12 | X | A | 7,365 | $2.05 | 148,941 | D | — | — | (F1) The number of shares beneficially owned, as reported on the Form 4 filed on June 13, 2023, erroneously included options held by the Reporting Person. |
| 2 | Derivative | Warrant (right to buy) | 2023-06-12 | X | D | 7,365 | $0.00 | 0 | D | $2.05 · 2022-06-09 to 2027-06-09 | 7,365 Common Stock |